New injection aims to melt dangerous neck plaques in High-Fat patients
NCT ID NCT07050134
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an injected drug called DR10624 in 40 adults with high triglycerides and fatty buildup in their neck arteries. Participants receive either the drug or a placebo for 24 weeks, with doses gradually increased. The main goal is to see if the drug reduces artery wall thickness and plaque size, which could lower heart attack and stroke risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CAROTID ATHEROSCLEROTIC PLAQUES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Suzhou Municipal Hospital
Suzhou, Jiangsu, 215001, China
-
The Central Hospital of Xuhui District
Shanghai, Shanghai Municipality, 200020, China
-
The First Affiliated Hospital of Anhui Medicaluniversity
Hefei, Anhui, 230022, China
-
Zhongshan Hospital Affiliated with Fudan University
Shanghai, Shanghai Municipality, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Plant-Based protein switch reshape your metabolism?
- Fish oil pills put to the test: can they tame high triglycerides?
- Weekly shot aims to tame dangerous fat levels in the blood
- Could ozempic stop pancreatitis from coming back?
- New shot aims to tame dangerous fat levels in blood
- New drug RBD5044 aims to lower high triglycerides in phase 2 trial